SCHEMBL757323

SCHEMBL757323

COc1cc(C(=O)NCCc2c(C)[nH]c3ccccc23)ccc1-n1cnc(C)c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 6/20 0.64
PSEN2 P49810 6/20 0.64
APH1B Q8WW43 6/20 0.64
NCSTN Q92542 6/20 0.64
APH1A Q96BI3 6/20 0.64
PSENEN Q9NZ42 6/20 0.64
ATM Q13315 1/20 0.59
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 10/20 0.47
PABPC1 P11940 1/20 0.46
ALOX15 P16050 1/20 0.46
LMNA P02545 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
POLB P06746 2/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GPR142 Q7Z601 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759649 0.91 PSEN1 (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL758858 0.84 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3230797 0.83 ATM (0.66) ATMMEN1KMT2AMAPTPABPC1
SCHEMBL758946 0.80 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6852566 0.80 PSEN1 (0.73) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL758647 0.80 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3381318 0.79 MAPT (0.70) ATMMEN1KMT2AMAPTPABPC1
SCHEMBL761534 0.79 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL758934 0.78 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL758281 0.78 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.